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Annually, during the evaluation process of the 
Graduate Programs in Brazil, the discussion about the 
Qualis journals classification resurfaces. In late 2016, 
the CAPES’s (Brazilian Federal Agency for Support 
and Evaluation of Postgraduate Education) pharmacy 
webpage1 published three important documents: 
(i) the 2017 Document of the Pharmacy Area, (ii) the 
Considerations on the Qualis Journals Classification 2016, 
and (iii) the article by Rita de Cassia Barradas Barata 
“Ten things you should know about the Qualis” (Barata, 
2016). These documents explain in detail how the criteria 
for the journals classification in the scope of Postgraduate 
Programs evaluation are defined, including the purposes, 
applications and limitations of the system. 
The system is based on strata pre-established by 
the CAPES Board of Directors, where A1 <A2, A1 + A2 
≤ 25% and A1 + A2 + B1 ≤ 50% of the total number of 
journals in which academics published their articles in 
the time period under review. The criteria for defining 
and distributing the scientific journals in each stratum are 
established by respective areas of evaluation, which may 
result in different classifications for the same journal in 
each of these areas. In view of that, this is an opportune 
time to discuss the criteria used by the Pharmacy area 
towards a classification that more well-balancedly 
comprises the various fields of knowledge related to 
Postgraduate Programs in the Pharmacy area.
Concerning the two bibliographic databases used 
by the area – (1) Web of Science® (former Web of 
Knowledge)/Thomson Reuters and (2) Scopus/SCImago/
Elsevier –, it is crucial to understand some aspects of their 
structuring and purposes, and the bibliometric indicators 
used to analyze the journals.
Web of Science® is a comprehensive research 
platform whose rights belong to Thomson Reuters 
Publishing, with publications in the areas of science, 
social sciences, arts and humanities. The database allows 
evaluating and comparing journals with citation data 
drawn from approximately 12,000 academic and technical 
journals and conference proceedings from more than 
3,300 publishers in over 60 countries. It is connected to 
the InCites tool and the Journal Citation Reports (JCR) 
module so it provides citation metrics and indicators of 
contents linked to Web of Science.
Scopus is a database whose rights belong to Elsevier 
Publishing and contains articles, abstracts, conference 
proceedings, books, among others, with about 67 million 
records. In 2016, the database counted 22,794 peer-
reviewed journals, of which 3,643 are full open access. 
In the health area, it offers full coverage of the Medline 
database. 
For the journals to be indexed in those databases, 
they are analyzed according to criteria pre-established 
by their respective publishers. The initiative is usually 
from the publisher of the journal and, once approved, 
maintenance expenses are to be paid. For this reason, 
the first limitation of such systems concerns the indexed 
journals databases themselves, and consequently the 
market dispute between two of the world’s largest 
scientific publishers (Oosthuizen, Fenton, 2014). The 
two databases in question offer bibliometric indicators 
to measure the prestige of the indexed journals. These 
indicators are essentially based on citation indices, usually 
from recent years, referred to as “impact factor”. 
However, the pattern of article citation is highly 
variable in the various fields of knowledge. Examples 
that illustrate this point are the journals in the field of 
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mathematics, which generally accept about ten references 
and show a tendency of citations of old, usually classic, 
articles on the subject. Another example is the field of 
biological sciences, whose journals accept a greater number 
of references (about 40) and the cited articles tend to be 
recent ones (Fonseca, 2015; Andrés, 2011; Pendlebury, 
2009). In this sense, the two databases under analysis 
classify the journals into categories, considering the scope 
of the journal and its characteristics. For instance, in 2015 
the median JCR impact factor for the Mathematics category 
was 0.614, while for the Biochemistry & Molecular Biology 
category it was 2,670. In addition, the number of journals 
is variable and, consequently, the total number of citations. 
Therefore, the Journal Impact Factor (JIF) allows 
comparisons among journals only within a given 
subject category, as explained by the very databases. 
The two databases in question provide other metrics for 
the comparison among different categories, which are 
displayed in Table I.
According to the document ‘Considerations on 
the Qualis Journals Classification 2016’, the Pharmacy 
area used as a classification criterion the Impact Factor 
TABLE I - Bibliometric indicators available from the databases Web of Science/Thomson Reuters and Scopus/SCImago/Elsevier
Indicator Database Description
JIF Journal Impact 
Factor 
Web of Science /
Thomson Reuters
It measures the citation index of the journal, that is, the number of 
citations received by articles published in the journal in the two years 
prior to the evaluation, divided by the number of articles published in the 
period, including self-citations. It considers original articles, reviews and 
conference proceedings. According to its creator, this indicator does not 
allow the comparison among journals of different categories, since 
these can have great variability of size and citation behaviors.
JIF Percentil Web of Science /Thomson Reuters
It calculates the JIF percentiles in each subject category, considering the 
ranking of the journal in the respective category. Since a journal may 
appear in more than one category, it will display a JIF percentile value 
for each category.
JIF Quartile Web of Science /Thomson Reuters
As a comparative measure, based on JIF percentiles in each subject 
category, journals are classified into quartiles (Q1, Q2, Q3 and Q4) in the 
respective categories. As a journal may appear in more than one category, 
it can have more than one “Q”.
Average JIF percentil Web of Science /Thomson Reuters
With the percentiles of each subject category in which the journal is 
classified, an average is calculated. It allows, according to the database, 
comparing journals of different areas. (http://www.istl.org/09-spring/
refereed1.html)
CiteScore Scopus/SCImago/Elsevier
It considers the number of citations received in the three years prior to the 
evaluation, divided by the number of documents published in the same 
period. It considers original articles, reviews, conference proceedings, 
editorials, errata, letters, notes, and short surveys.
CiteScore rank Scopus/SCImago/Elsevier
It calculates the CiteScore percentiles in each category of the Scopus 
database, considering the ranking of the journal in the respective 
category. A journal will have a percentile value for each category in 
which it is ranked.
SJR SCImago Journal 
Rank
Scopus/SCImago/
Elsevier
It measures the weighted citations received by the journal. The indicator 
is calculated using an iterative algorithm that distributes prestige values 
among journals until a stable solution is reached. The weighting 
considers the category and the prestige of the citation.
SNIP Source 
Normalized Impact per 
Paper
Centre for Science and 
Technology Studies (CWTS), 
University of Leiden/ 
Scopus/ Elsevier
It measures the citation impact of scientific journals. It considers 
the categories in which the journals are classified, smoothing out 
differences such as the number of citations per article, the limit of 
references accepted and the speed of the publication process. It allows 
comparing among journals of different categories within the Scopus 
database.
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indicator from database (1) Web of Science/Thomson 
Reuters for strata A1 to A2, and a combination of this and 
the SJR (SCImago Journal Rank) indicator from database 
(2) Scopus/SCImago/Elsevier for strata B1 to B4. In these 
cases, the indicator with the highest value was chosen to 
classify each journal in the mentioned strata. The indexed 
journals in the databases PubMed/Medline, Scielo and 
LILACS – instead of ISI/Web of Knowledge/Thomson 
Reuters and Scopus/SCImago/Elsevier – determined the 
classification B5. 
The ‘2017 Document of the Pharmacy Area’ 
emphasizes the multidisciplinary and interdisciplinary 
nature of the Pharmacy area, which is evidenced by 
the diversity of the professors’ doctoral careers, the 
engagement of professors in other programs of different 
CAPES evaluation areas, and the profile of publications 
in the area.
Regarding the publications in the area, the document 
shows that the 25 scientific journals most used by 
professors from Pharmacy programs represent less than 
2.0% of the Qualis of the area and more than 15.0% of 
the articles published in the period under consideration. 
These journals are classified in a wide variety of categories 
in both the Web of Science and Scopus databases. These 
data express the need for indicators that take such a 
diversity into account. Table I shows some examples of 
journals, in the 2015 Qualis classification, the categories 
to which the journals belong in the two databases, and the 
respective indicators.
Initially, it can be seen that the values attributed to 
the JIF and CiteScore indicators show a greater proximity 
between themselves than between those to JIF and SJR. 
This was expected since the SJR indicator measures the 
weighted citations, considering the categories. 
However, the percentiles of the journals’ ranking 
in the respective categories indicate a variation, which 
is a consequence of the variation in the citation profile 
of the journals, as per the characteristics of the fields of 
knowledge. Therefore, it would be more appropriate to use 
the journals’ ranking in the categories to compare journals 
of different categories. The JCR database, particularly, 
provides each journal with the Average JIF % indicator; 
in the case of the Scopus database, the corresponding value 
can be calculated.
Although the JIF and CiteScore indicators, and 
respective percentiles, are based on similar assumptions, 
the values are different for the same journal, since they 
use their own systems, which depend on the journal’s 
registration in the database. The two databases under 
analysis are key for the Pharmacy area, especially in strata 
A1 and A2, as most journals are registered in the two of 
them. With respect to the percentiles, among the 25 most 
cited journals used in the area, the majority of them has 
a higher average percentile value in the categories of the 
Scopus database than in that of JCR.
Finally, it is worth noting that these indicators have 
been internationally discussed as to their applicability 
for evaluating the quality of publications (Fonseca, 
2015). The use of the designation ‘Impact Factor’ for the 
citation index calculation in a recent period leads to the 
misinterpretation that this represents the impact of the 
journal. The citation per se does not necessarily mean 
that the article has quality. The classic example is the 
publication on cold fusion, which received between the 
years 1988-1992 approximately 700 citations, but largely 
negative ones (http://www.scielo.br/pdf/qn/v22n3/1101.
pdf). Moreover, these indicators measure only recent 
citations and do not consider the classic references, which 
are generally of greater academic impact. 
Considering that both the (1) Web of Science/
Thomson Reuters and (2) Scopus/SCImago/Elsevier 
databases provide bibliometric indicators that allow 
comparing the impact/quality of the journals, it seems to 
be outdated to classify the journals based on the impact 
factor using absolute counts instead of relative measures 
(Pendlebury, 2009).
Another point to consider about the system is the 
induced preference for publishing in high-ranked journals, 
which can be classified in a certain stratum – regardless of 
the bibliometric indicators used – due to their relevance 
to the area. The Pharmacy area has four induced journals, 
two of them are classified as B2, one B3, and the other B5. 
Considering that the journals classification criteria 
in the different areas of the Qualis system evaluation are 
defined by each corresponding area, it is worth noting 
that there is space and an urgent need to deeply discuss 
the fact that, ultimately, the evaluation should underline 
aspects such as: the current system’s real contribution 
to the quality assessment of the publications; possible 
biases; and the perspectives towards proposing a more 
balanced and consistent system embracing the multi- and 
interdisciplinary nature of the Pharmacy area.
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